Relief Therapeutics Holding AG (RLFTF)

[GreenKnight]

100% my thinking... DSMB can adjudicate ... this is not “new” and is safe so why shouldn’t it be fast-tracked with Dr. Javitt’s pedigree, and why do we need more patients if the original target was 120 and now they have been OKAY’d at 102!!! Something tells me that we see interim results in near order because of this:

“Intervention Model Description:
Multicenter trial, initially conducted at a single center with a safety/futility assessment following enrolment of 30 patients.”

Have we seen that yet??? Says the page was last updated August 31st 2020. Because DSMB calls the shots here, we are going to get an interim update soon which says “safe and showing <insert qualifier here> (some? Significant?) efficacy for ARDS from COVID-19 in patients on ventilators.

IMO